Hans-Peter Ekre, Chairman of the Board, Investment Manager, Karolinska Development, previously held senior managerial positions in drug discovery and development within the pharmaceutical industry, including Director of Pharmacology at Kabi-Pharmacia and Astra Draco (AstraZeneca in Lund).

Per-Johan Jakobsson, MD, PhD, Associate Professor, Member of the Board, Medical Biochemist, Researcher and Physician at the Department of Rheumatology Karolinska University Hospital. Founder.

Ralf Morgenstern, PhD, Professor, Member of the Board, Biochemist, Researcher at the Department of Environmental Medicine, Karolinska Institutet. Founder.

Bertil Samuelsson, PhD, Professor, Member of the Board, Vice President, Discovery Research, Medivir, previously Head of Medicinal Chemistry at AstraZeneca.

Jan Sandström, Member of the Board, M.Sci Pharm. Consultant for biotech companies. Previously Senior Management positions in Sales, Marketing and Business Development at Astra/AstraZeneca, Orexo and other biotech companies.